DBV Technologies SA (DBVT)
9.80
+0.25
(+2.62%)
USD |
NASDAQ |
Oct 09, 16:00
9.86
+0.06
(+0.61%)
Pre-Market: 20:00
DBV Technologies Free Cash Flow : -152.18M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2026 | -152.18M |
| December 31, 2025 | -122.18M |
| September 30, 2025 | -98.74M |
| June 30, 2025 | -89.11M |
| March 31, 2025 | -90.47M |
| December 31, 2024 | -106.82M |
| September 30, 2024 | -108.72M |
| June 30, 2024 | -105.49M |
| March 31, 2024 | -95.40M |
| Date | Value |
|---|---|
| December 31, 2023 | -80.33M |
| September 30, 2023 | -90.19M |
| June 30, 2023 | -90.99M |
| March 31, 2023 | -75.76M |
| December 31, 2022 | -56.42M |
| September 30, 2022 | -47.88M |
| June 30, 2022 | -50.40M |
| March 31, 2022 | -70.04M |
| December 31, 2021 | -104.81M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cellectis SA | -45.36M |
| Akari Therapeutics Plc | -10.74M |
| EDAP TMS SA | -- |
| Bicycle Therapeutics Plc | -207.47M |
| Autolus Therapeutics Plc | -240.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -52.52M |
| Cash from Investing (Quarterly) | -0.5998M |
| Cash from Financing (Quarterly) | -0.1356M |
| Free Cash Flow Per Share (Quarterly) | -0.58 |
| Free Cash Flow to Equity (Quarterly) | -44.30M |
| Free Cash Flow to Firm (Quarterly) | -49.68M |
| Free Cash Flow Yield | -39.08% |